Treatment of Indolent Ulcer with cultured canine mesenchymal stem cells

Research Article


Abstract views: 0 / PDF downloads: 0

Authors

  • Jonathan RT Lakey

DOI:

https://doi.org/10.58372/2835-6276.1226

Keywords:

Dog, Stem cell, Indolent, ulcers, companion pet

Abstract

Background: Indolent ulcers are noninfectious epithelial defects of the cornea, typically presenting as chronic, superficial lesions. These ulcers are most commonly observed in dogs and are the leading cause of ophthalmic consultation in the UVS Ophthalmology service. These ulcers, which are more common in older dogs, often have difficulty healing naturally. Underlying eye conditions and infections can further hinder the healing process, potentially causing vision impairment and eventually removal of the eye. In this manuscript, we present the success of using mesenchymal stem cells (MSC) in a preliminary pilot trial to treat indolent ulcers.

Methods: Companion animals with indolent eye ulcers that did not respond to traditional treatment protocols were treated with suspended canine bone marrow-derived MSCs (5 x 105 cells total) administered via an eyedropper and then monitored for a period of 2-3 hours post infusion before being released back to their owners. Dogs had a follow up visit after 48-72 hours by the veterinary team.

Results: Of the 12 adult canine pets with indolent ulcers, MSC treatment led to recovery of the ulcers within 5-6 weeks after administration.

Conclusions: This pilot trial showed the promise of the use of topical canine MSC for dogs with indolent ulcers. In the near future we are planning to conduct a randomized prospective trial. We consider the use of expanded stem cells to treat indolent ulcers represent a novel and potentially effective approach and it is our intention to further expand the use of MSCs in the indication of ocular indolent ulcers.

References

Murphy CJ, Marfurt CF, McDermott A, Bentley E, Abrams GA, Reid TW et al: Spontaneous chronic corneal epithelial defects (SCCED) in dogs: clinical features, innervation, and effect of topical SP, with or without IGF-1. Invest Ophthalmol Vis Sci 2001, 42(10):2252-2261.

Meurs KM, Montgomery K, Friedenberg SG, Williams B, Gilger BC: A defect in the NOG gene increases susceptibility to spontaneous superficial chronic corneal epithelial defects (SCCED) in boxer dogs. BMC Vet Res 2021, 17(1):254.

Stanley RG, Hardman C, Johnson BW: Results of grid keratotomy, superficial keratectomy and debridement for the management of persistent corneal erosions in 92 dogs. Vet Ophthalmol 1998, 1(4):233-238.

Bentley E, Abrams GA, Covitz D, Cook CS, Fischer CA, Hacker D et al: Morphology and immunohistochemistry of spontaneous chronic corneal epithelial defects (SCCED) in dogs. Invest Ophthalmol Vis Sci 2001, 42(10):2262-2269.

Bentley E: Spontaneous chronic corneal epithelial defects in dogs: a review. J Am Anim Hosp Assoc 2005, 41(3):158-165.

Gosling AA, Labelle AL, Breaux CB: Management of spontaneous chronic corneal epithelial defects (SCCEDs) in dogs with diamond burr debridement and placement of a bandage contact lens. Vet Ophthalmol 2013, 16(2):83-88.

Boutin MP, Coutellier M, Ollivier FJ: Cotton-tip debridement, scalpel blade debridement, and superficial grid keratotomy for treatment of spontaneous chronic corneal epithelial defects (SCCED): A retrospective evaluation of 308 cases. Vet Ophthalmol 2020, 23(6):979-986.

Bacakova L, Zarubova J, Travnickova M, Musilkova J, Pajorova J, Slepicka P et al: Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review. Biotechnol Adv 2018, 36(4):1111-1126.

Ledbetter EC, Munger RJ, Ring RD, Scarlett JM: Efficacy of two chondroitin sulfate ophthalmic solutions in the therapy of spontaneous chronic corneal epithelial defects and ulcerative keratitis associated with bullous keratopathy in dogs. Vet Ophthalmol 2006, 9(2):77-87.

Hung JH, Leidreiter K, White JS, Bernays ME: Clinical characteristics and treatment of spontaneous chronic corneal epithelial defects (SCCEDs) with diamond burr debridement. Vet Ophthalmol 2020, 23(4):764-769.

Brunott A, Boeve MH, Velden MA: Grid keratotomy as a treatment for superficial nonhealing corneal ulcers in 10 horses. Vet Ophthalmol 2007, 10(3):162-167.

Mansoor H, Ong HS, Riau AK, Stanzel TP, Mehta JS, Yam GH: Current Trends and Future Perspective of Mesenchymal Stem Cells and Exosomes in Corneal Diseases. Int J Mol Sci 2019, 20(12).

Jiang Y, Lin S, Gao Y: Mesenchymal Stromal Cell-Based Therapy for Dry Eye: Current Status and Future Perspectives. Cell Transplant 2022, 31:9636897221133818.

Samaeekia R, Rabiee B, Putra I, Shen X, Park YJ, Hematti P et al: Effect of Human Corneal Mesenchymal Stromal Cell-derived Exosomes on Corneal Epithelial Wound Healing. Invest Ophthalmol Vis Sci 2018, 59(12):5194-5200.

An S, Anwar K, Ashraf M, Lee H, Jung R, Koganti R et al: Wound-Healing Effects of Mesenchymal Stromal Cell Secretome in the Cornea and the Role of Exosomes. Pharmaceutics 2023, 15(5).

Downloads

Published

2024-11-06

How to Cite

Jonathan RT Lakey. (2024). Treatment of Indolent Ulcer with cultured canine mesenchymal stem cells: Research Article. American Journal of Medical and Clinical Research & Reviews, 3(11), 1–6. https://doi.org/10.58372/2835-6276.1226

Issue

Section

Articles